Mercer County v. Purdue Pharma L.P. et al
Filing
1
COMPLAINT against Abbvie Inc., Actavis LLC, Actavis Pharma, Inc., Allergan Finance LLC, Allergan PLC, AmerisourceBergen Corporation, CVS Health, Cardinal Health, Inc., Cephalon, Inc., Covidien PLC, Does 1-100, Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Knoll Pharmaceutical Company, Kroger Company, The, Mallinckrodt Brand Pharmaceuticals, Mallinckrodt PLC, Mallinckrodt, LLC, McKesson Corporation, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Purdue Pharma Inc., Purdue Pharma L.P., Qualitest Pharmaceutical Inc., Rite Aid Corporation, SpecGx LLC, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., The Purdue Frederick Company, Wal-Mart Stores, Inc., Walgreens Boot Alliance, Inc., Watson Laboratories, Inc. (Filing fee $400, receipt number 319000360) filed by Mercer County. (Attachments: #1 Civil Cover Sheet)(am) [Transferred from ndd on 7/19/2019.]
Plaintiff
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 1 OF 70
Defendants
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 2 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 3 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 4 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 5 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 6 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 7 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 8 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 9 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 10 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 11 OF 70
See
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 12 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 13 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 14 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 15 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 16 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 17 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 18 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 19 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 20 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 21 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 22 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 23 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 24 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 25 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 26 OF 70
10
11
Good Morning America television broadcast, ABC News (Aug. 30, 2010).
Thomas Catan & Evan Perez, A Pain-Drug Champion Has Second Thoughts, WALL ST. J., Dec. 17, 2012.
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 27 OF 70
12
13
Id.
Id.
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 28 OF 70
John Fauber & Ellen Gabler, Networking Fuels Painkiller Boom, MILWAUKEE WISC. J. SENTINEL (Feb. 19,
2012).
14
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 29 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 30 OF 70
Interview by Paula Moyer with Scott M. Fishman, M.D., Professor of Anesthesiology and Pain Medicine, Chief of
the Division of Pain Medicine, Univ. of Cal., Davis (2005), http://www.medscape.org/viewarticle/500829.
16
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 31 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 32 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 33 OF 70
Treatment Options: A Guide for People Living with
Pain
Living with Someone
with Chronic Pain
Finding Relief: Pain Management for Older Adults
A Policymaker’s Guide to Understanding Pain & Its
Management
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 34 OF 70
CDC Guideline for Prescribing Opioids for Chronic Pain – United States 2016, Centers for Disease Control and
Prevention (Mar. 18, 2016).
17
Id.
FDA Announcement of Enhanced Warnings for Immediate-Release Opioid Pain Medications Related to Risks of Misuse, Abuse,
Addiction, Overdose and Death, Federal Drug Administration (Mar. 22, 2016).
20 Id.
21 Id.
18
19
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 35 OF 70
Responsible Opioid Prescribing
Responsible Opioid
Prescribing
Let’s Talk Pain
Chronic Opioid Therapy: Understanding Risk While Maximizing
Analgesia
Providing Relief, Preventing
Abuse
Path of the Patient, Managing
Chronic Pain in Younger Adults at Risk for Abuse
22
23
See, e.g., OxyContin label and insert at OxyContin.com.
Id.
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 36 OF 70
Journal of Family Practice
Pain Management Dilemmas in Primary Care: Use of
Opioids
CDC Guidelines for Prescribing Opioids for Chronic Pain, supra.
25
Id.
26
Id.
27
Id.
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 37 OF 70
Managing Patient’s Opioid Use: Balancing
the Need and Risk
Persistent Pain in the Older
Adult
A Policymaker’s Guide to Understanding
Pain & Its Management
CDC Guidelines for Prescribing Opioids for Chronic Pain, supra.
29
See id.
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 38 OF 70
30
31
CDC Guidelines for Prescribing Opioids for Chronic Pain, supra.
Id.
32
Id.
33
CDC Guidelines for Prescribing Opioids for Chronic Pain, supra.
34
Id.
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 39 OF 70
APF’s Treatment Options: A Guide for People Living with
Pain
Understanding Your Pain:
Taking Oral Opioid Analgesics
Finding Relief: Pain
Management for Older Adults
In the Face of Pain
A Policymaker’s Guide to Understanding Pain & Its
Management
Overview of Management Options
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 40 OF 70
CDC Guidelines for Prescribing Opioids for Chronic Pain, supra.
Id.
37 Id.
38 Id.
35
36
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 41 OF 70
39
See FDA Statement: Original Opana ER Relisting Determination (May 10, 2013).
40
CDC Guidelines for Prescribing Opioids for Chronic Pain, supra.
41
Id.
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 42 OF 70
Finding Relief:
Pain Management for Older Adults
42
Id.
43
Id.
Letter from Janet Woodcock, M.D., Dir., Ctr. For Drug Eval. & Res., to Andrew Kolodny, M.D., Pres.
Physicians for Responsible Opioid Prescribing, Re Docket No. FDA-2012-P-0818 (Sept. 10, 2013).
44
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 43 OF 70
Responsible Opioid Prescribing
Treatment Options: A Guide for People Living with
Pain
painknowledge.com
Persistent Pain in the Older Patient
Let’s Talk Pain
A Policymaker’s
Guide to Understanding Pain & Its Management
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 44 OF 70
CDC Guidelines for Prescribing Opioids for Chronic Pain, supra.
Id.
47 Id.
48 Id.
49 Id.
50 Id.
51 Warning Letter from Thomas Abrams, Dir., FDA Div. of Mktg., Adver., & Commc’ns, to Doug Boothe, CEO,
Actavis Elizabeth LLC (Feb. 18, 2010), http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/
EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/
45
46
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 45 OF 70
ucm259240.htm.
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 46 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 47 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 48 OF 70
See B a r r y M e i e r , “ In G u i l t y P l e a , O x y C o n t i n M a k e r t o P a y $ 600 M i l l i o n ,” ( May 1 0 , 2 0 0 7 ),
http://www.nytimes.com/2007/05/10/business/11drug-web.html.
53 See id.
54 See id.
52
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 49 OF 70
Hazelden Betty Ford Foundation, Missed Questions, Missed Opportunities (Jan. 27, 2016), available at
http://www.hazeldenbettyford.org/about-us/news-and-media/pressrelease/doctors-missing-questions-that-couldprevent-opioid-addiction.
55
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 50 OF 70
CDC. National Vital Statistics System, Mortality. CDC WONDER. Atlanta, GA: US Department of Health and
Human Services, CDC; 2016. https://wonder.cdc.gov/; Rudd RA, Seth P, David F, Scholl L. Increases in Drug and
Opioid-Involved Overdose Deaths — United States, 2010–2015. MMWR Morb Mortal Wkly Rep. ePub: 16
December 2016.
National Vital Statistics System, Mortality file and appearing Center for Disease Control and Prevention Morbidity and
Mortality Weekly Report, January 1, 2006 / 64(50); 1378-82, Increases in Drug and Opioid Deaths – United States, 20002014.
CDC Guideline for Prescribing Opioids for Chronic Pain, supra; see also Rudd RA, Seth P, David F, Scholl L. Increases in
Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015. MMWR Morb Mortal Wkly Rep. ePub:
16 December 2016.
Opinion of the Attorney General of Texas, KP-0168 (Oct. 4, 2017).
Id. citing http://www.nchrc.org/law-enforcement/us-law-enforcement-who-carry-naloxone/.
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 51 OF 70
Nathaniel P. Katz, Prescription Opioid Abuse: Challenges and Opportunities for Payers, Am. J. Managed Care (Apr. 19 2013),
at 5 (“The most common source of abused [opioids] is, directly or indirectly, by prescription.”),
http://www.ajmc.com/publications/issue/2013/2013-1-vol19-n4/Prescription-Opioid-Abuse-Challenges-andOpportunities-for-Payers.
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 52 OF 70
Centers for Disease Control and Prevention. Vital Signs: Today’s Heroin Epidemic – More People at Risk,
Multiple Drugs Abused. (https://www.cdc.gov/vitalsigns/heroin/index.html). MMWR 2015.
63 https://www.cdc.gov/vitalsigns/heroin/index.html
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 53 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 54 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 55 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 56 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 57 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 58 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 59 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 60 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 61 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 62 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 63 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 64 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 65 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 66 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 67 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 68 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 69 OF 70
PLAINTIFF’S ORIGINAL COMPLAINT
PAGE 70 OF 70
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?